Healthcare Realty Trust (NYSE:HR) Given New $16.00 Price Target at Wedbush

Healthcare Realty Trust (NYSE:HR - Get Free Report) had its price target cut by equities researchers at Wedbush from $18.00 to $16.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a "neutral" rating on the real estate investment trust's stock. Wedbush's price target indicates a potential upside of 6.07% from the stock's current price.

Several other analysts have also weighed in on the stock. StockNews.com upgraded shares of Healthcare Realty Trust from a "sell" rating to a "hold" rating in a research note on Wednesday, April 30th. Wells Fargo & Company lowered their price objective on shares of Healthcare Realty Trust from $17.00 to $16.00 and set an "underweight" rating for the company in a research report on Monday, March 10th. Finally, Scotiabank decreased their target price on Healthcare Realty Trust from $18.00 to $17.00 and set a "sector perform" rating for the company in a research note on Tuesday, February 25th. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. According to data from MarketBeat.com, Healthcare Realty Trust currently has an average rating of "Hold" and an average price target of $17.00.

Healthcare Realty Trust Stock Down 0.8 %

Shares of HR traded down $0.13 during midday trading on Monday, hitting $15.09. The company had a trading volume of 717,439 shares, compared to its average volume of 3,252,359. Healthcare Realty Trust has a 52 week low of $14.53 and a 52 week high of $18.90. The company's 50 day moving average price is $16.20 and its 200 day moving average price is $16.82. The stock has a market cap of $5.29 billion, a price-to-earnings ratio of -8.48 and a beta of 0.92.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.39. The firm had revenue of $288.86 million for the quarter, compared to analysts' expectations of $297.39 million. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. Healthcare Realty Trust's revenue for the quarter was down 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.39 earnings per share. Equities analysts anticipate that Healthcare Realty Trust will post 1.59 EPS for the current fiscal year.

Institutional Investors Weigh In On Healthcare Realty Trust

Several large investors have recently made changes to their positions in HR. Golden State Wealth Management LLC bought a new position in Healthcare Realty Trust in the 1st quarter worth approximately $26,000. Smartleaf Asset Management LLC increased its holdings in shares of Healthcare Realty Trust by 59.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 612 shares during the period. Blue Trust Inc. raised its stake in shares of Healthcare Realty Trust by 130.3% during the fourth quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares in the last quarter. Synergy Investment Management LLC acquired a new stake in Healthcare Realty Trust in the fourth quarter worth about $36,000. Finally, Lazard Asset Management LLC bought a new stake in shares of Healthcare Realty Trust during the 4th quarter worth about $45,000.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.